Skip to main content

Table 2 Baseline characteristics according to categorization of asthma diagnosis n = 338

From: Asthma medication in children who are overweight/obese: justified treatment?

 

No n = 64 (18.9)

Unlikely n = 44 (13.1)

Probable n = 168 (49.7)

Confirmed n = 62 (18.3)

P-value

Age (years)

8.8 (4.2–16.2)

8.5 (4.1–17.1)

9.5 (4.2–16.9)

7.8 (4.0–17.7)

0.119

Male n (%)

34 (53.1)

27 (61.4)

108 (64.3)

40 (64.5)

0.444

Height (cm)

135.5 (103.3–178.5)

135.2 (104.8–177.1)

139.0 (105.0–196.6)

132.2 (99.5–178.6)

0.226

Height-sds

0.03 (−2.95–1.82)

0.24 (−1.75–2.57)

−0.09 (− 2.37–2.65)

0.10 (− 2.23–1.51)

0.433

Weight (kg)

40.9 (19.2–80.6)

35.8 (18.6–85.4)

40.2 (19.1–103.0)

35.9 (15.7–127.0)

0.212

BMI (kg/m2)

21.06 (16.72–30.22)

20.36 (16.65–30.17)

20.84 (16.65–36.35)

19.89 (17.76–39.81)

0.369

BMI-sds

2.09 (1.11–4.23)

1.97 (1.13–4.36)

1.96 (1.11–5.24)

1.93 (1.11–4.19)

0.663

BMI-categories

   

0.905

 - Overweight

41 (64.1)

29 (65.9)

115 (68.5)

43 (69.4)

 

 - Obesity

23 (35.9)

15 (34.1)

53 (31.5)

19 (30.6)

 

Spirometry

43 (67.2)

28 (63.6)

131 (78.0)

49 (79.0)

0.101

Reversibility ≥12%

40 (64.5)

< 0.001

Clinical diagnosis

168 (100)

56 (90.3)

< 0.001

Clinical diagnosis and reversibility ≥12%

34 (54.8)

< 0.001

Prescribed asthma medication n (%)

  

< 0.001

 - β2-agonist

25 (39.1)

37 (84.1)

24 (14.3)

13 (21.0)

 

 - ICS

4 (6.3)

20 (11.9)

14 (22.6)

 

 - Both

26 (40.6)

116 (69.0)

34 (54.8)

 

 - No

9 (14.1)

7 (15.9)

8 (4.8)

1 (1.6)

 
  1. Data presented as number (%) or median with range. BMI body mass index, sds standard deviation score, ICS Inhaled Corticosteroids